Quarterly Result28 May 2026, 10:09 pm
SHELTER PHARMA Board Approves FY26 Results, Appoints Internal Auditor
AI Summary
The Board of Directors of SHELTER PHARMA LIMITED convened on May 28, 2026, approving the Standalone Audited Financial Results for the half year and full year ended March 31, 2026. The company submitted these results, accompanied by an Auditor's Report with an unmodified opinion, in compliance with SEBI (LODR) Regulations, 2015. Additionally, the Board appointed CA Ismail Ibrahimbhai Lakhani (M/S. I I LAKHANI & CO) as the Internal Auditor for the financial year 2026-27.
Key Highlights
- Board of Directors met on May 28, 2026.
- Approved Standalone Audited Financial Results for FY26.
- Auditor's Report on results received unmodified opinion.
- Appointed M/S. I I LAKHANI & CO as Internal Auditor for FY27.
- Filing complies with SEBI (LODR) Regulations, 2015.
Price Impact
More from SHELTER